Additionally, a SIRT1 inhibitor effectively suppressed tumor growth in a mouse xenograft model without significant toxicity, suggesting that SIRT1 plays a key role in autophagy-driven drug resistance in oesophageal cancer. This evidence concerns the gene SIRT1 and carcinoma of esophagus.